Amanda Tong
@AmandaTong2013
Followers
514
Following
2K
Media
15
Statuses
264
Cardiologist, Physician-Scientist. Assistant Professor @UTSW. Studying HFpEF and Afib.
Joined May 2013
We are still recruiting @UTSWMedCenter !! 🔥🔥🔥Look for a postdoctoral fellow to join us in studying the molecular mechanisms of HFpEF and atrial fibrillation. Prior experience in cardiac pathophysiology, immunology and bioinformatics is preferred but not required.
0
4
12
Excellent opportunity 👇👇👇
Please repost. Postdoc position available to decipher metabolic mechanisms that drive cardiovascular disease. Join our exciting lab in New York City! Many career development opportunities.
0
0
1
Please help to repost ⏰⏰⏰ The Tong Lab @UTSWMedCenter is recruiting a postdoctoral fellow to join us in studying the molecular mechanisms of HFpEF and atrial fibrillation. Prior experience in cardiac pathophysiology, immunology and bioinformatics is preferred but not required.
3
18
39
It correlates well with the degree of LV pathology, wedge pressure, poor functional status and survival. Next question -- whether HFpEF therapies (SGLT2i, GLP1RA, and MRA) can improve symptoms and outcomes in these patients?
0
0
1
By simple three clinical parameters (age, BMI and Afib), the HFpEF-ABA prediction can help to better determine the pre-test probability of HFpEF, thus help to select patients for invasive exercise RHC testing. https://t.co/WtXOK4CTVX
https://t.co/oKQm7akcOE
ahajournals.org
BACKGROUND: Patients with lung disease, sleep apnea, and chronic thromboemboli can develop pulmonary hypertension, currently classified as group 3 or 4. Many of these patients also have risk factors...
1
0
1
I receive frequent referrals from my PH colleagues. Many patients with pulmonary hypertension (group 1, 3 and 4) have shared/overlapped risk factors for HFpEF, and have symptoms disproportionate to their underlying lung/vascular etiologies. How to better diagnose possible
1
1
5
3. Exercise hemodynamics abnormalities are prognostically significant.
0
0
3
Highlights from this study: 1. Routine resting RHC will miss a significant proportion of HFpEF patients (23-28% in this study). 2. Contemporary HFpEF trial criteria is specific enough to enrich HFpEF cases. However, seems not sensitive enough (exclude up to 83%), particularly
2
0
4
HFpEF is hard to diagnose. How to better diagnose HFpEF? Compared with gold standard exercise RHC, what's the performance of our society diagnostic criteria and contemporary HFpEF trial inclusion criteria? Beautiful study @CircRes. https://t.co/W1AH1VI5aR
ahajournals.org
2
12
38
TET2 mutant clonal hematopoiesis promotes heart failure with preserved ejection fraction via proinflammatory pathways @ambarish4786, @AmandaTong2013, @SChung_Lab, @UTSWMedCenter @mattsegar @daou_daniel @huwenhuo @PremnathNaveen
https://t.co/RNLeZKaQLV
2
13
37
The shift in cardiovascular disease. From reduction of heart attacks, coronary artery disease, and strokes to more atrial fibrillation ("the most common cardiovascular problem") https://t.co/pdfcYyM05Z
thelancet.com
Advances in cardiovascular disease prevention are often hailed as one of the major public health accomplishments of the past 50 years. The progress achieved is rooted in efforts challenging the...
6
82
319
Higher HFpEF probability in group 3/4 PH is associated with dynamic PCWP abnormalities, worse functional status and quality of life. @yreddyhf @mayoclinicCV @JaneALeopold @FrantzDrBob @WilsonTangMD @bborlaugmd @ebrosenzweig @SteveMathaiMD @ChrisJellisMD
https://t.co/B4IdpK0e1K
2
9
22
Using two independent HFpEF cohorts and a preclinical model, we demonstrated that TET2 mutant CHIP directly promotes HFpEF in a genotype-specific manner by promoting pro-inflammatory pathways, and is independently associated with worse clinical outcomes.
1
0
2
New paper alert! @CircAHA @utswheart The first paper from my independent lab! great collaboration with @SChung_Lab @ambarish4786. Congratulations to all the authors! https://t.co/TdUusFcqtL
ahajournals.org
12
6
41
I was so very honoured to talk to Professor @josephahill, EIC of the flagship #journal, @CircAHA. Brilliant, accomplished, genuine, & humble, he is an exemplar leader & role model. Listen to his insights into #MedicalPublishing in this unscripted discussion @radcliffeCARDIO.
NEW 🎓Masterclass on Medical Publishing in an Era of Disinformation Join host Dr @hvanspall for an expert interview with Dr @josephahill about his inspiring career journey, tackling medical misinformation, and the power of effective scientific communication. 📽️👉
5
10
45
Terrific discussion sharing pearls of wisdom for teaching our trainnees @utswheart. @GailPetersonMD @dramitkhera @AmitGoyalMD @melsulistio @JTThibs Dr. Darren McGuire & Dr. Gene Hu
0
4
17
0
3
42
What a marvelous day celebrating the 50th Anniversary of the University of Iowa Francois Abboud Cardiovascular Research Center and the legacy of Dr. Abboud! A huge thank you to all our guest speakers who made this event truly memorable.@UIowaACRC @IntMedatIowa @IowaMed
0
6
46
Please join us for an exciting Keystone symposium! 😀 N.B. Scholarship Deadline: (Nov 7, 2024) Abstract Deadline for Short Talk Consideration: (Nov 7, 2024) Early Registration Deadline: (Dec 18, 2024) Abstract Deadline for Poster Presentation: (Jan 21, 2025)
0
5
32